Cellectis S.A Capital Expenditures (CapEx) Growth & History (CLLS)

Cellectis S.A's capital expenditures (capex) was $2.4M for fiscal 2025.

View full Cellectis S.A company overview

Cellectis S.A annual capital expenditures (capex) history

Cellectis S.A annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31$2.4M−$223,000−8.63%
20242024-12-31$2.6M$1.5M+140.73%
20232023-12-31$1.1M−$1.4M−55.86%
20222022-12-31$2.4M−$16.1M−86.89%
20212021-12-31$18.5M−$25.5M−57.93%
20202020-12-31$44.1M$31.2M+241.33%
20192019-12-31$12.9M$8.2M+173.87%
20182018-12-31$4.7M$2.3M+97.86%
20172017-12-31$2.4M−$11.3M−82.60%
20162016-12-31$13.7M$9.4M+217.33%
20152015-12-31$4.3M

Cellectis S.A capital expenditures (capex) trends

Over the last five fiscal years, Cellectis S.A's capital expenditures (capex) decreased from $44.1M to $2.4M, a change of −$41.7M. The latest reported quarter, Q2 2026, shows $253,000.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Cellectis S.A source filings ↗

Community posts

It’s quiet here.

No posts about CLLS yet. Start the conversation.

Write the first post